Icon

PREVACID NAPRAPAC 250 (COPACKAGED) (nda021507)- (15MG,N/A;N/A,250MG)

LANSOPRAZOLE; NAPROXEN TAKEDA PHARMS NA
15MG,N/A;N/A,250MG
No No
Expired Expired
None None
None No
PREVACID NapraPAC is indicated for reducing the risk of NSAID-associated gastric ulcers in patients with a history of documented gastric ulcer(s) who require the use of an NSAID for treatment of the signs and symptoms of rheumatoid arthritis, osteoarthritis, and/or ankylosing spondylitis.
0 0 0
Total Other Developers None
Drugs with Suitability No
15MG,N/A;N/A,250MG ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.